ATOS
USDAtossa Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$0.843
High
$0.900
Low
$0.843
Volume
0.00M
Company Fundamentals
Market Cap
110.5M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.63M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,281,056, Including 58 Claims Covering Various Formulations for its (Z)-endoxifen Portfolio
SEATTLE, April 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today
Atossa Therapeutics Proposes Potentially Groundbreaking Study Aimed at Reducing Interval Breast Cancer in High-Risk Women at AACR 2025
SEATTLE, April 29, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today
Atossa Therapeutics Announces Issuance of U.S. Patent No. 12,275,684, Further Strengthening (Z)-endoxifen Portfolio
SEATTLE, April 22, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (NASDAQ:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines for breast cancer, today
Ascendiant Capital Maintains Buy on Atossa Therapeutics, Raises Price Target to $7.25
Ascendiant Capital analyst Edward Woo maintains Atossa Therapeutics with a Buy and raises the price target from $7 to $7.25.
Related Stocks
DUKB
Duke Energy Corporation 5.625% Junior Subordinated Debentures due 2078
SMTI
Sanara MedTech Inc.
SG
Sweetgreen Inc.
OZKAP
Bank OZK 4.625% Series A Non-Cumulative Perpetual Preferred Stock
CRF
Cornerstone Total Return Fund Inc. (The)
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.